📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence. (2021)

First Author: Zhu W

Attributed to: Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkab073

PubMed Identifier: 33590098

Publication URI: http://europepmc.org/abstract/MED/33590098

Type: Journal Article/Review

Volume: 49

Parent Publication: Nucleic acids research

Issue: 5

ISSN: 0305-1048